Postdoctoral Fellow Program

Skip to: Expectations, Terms of Appointment, Open Positions, Research Publications

Lilly's Postdoctoral Fellowship Program provides the opportunity for a Ph.D., M.D. or equivalent to gain and expand scientific expertise while working under the direct supervision of a senior Lilly scientist. The Postdoctoral Fellowship Program provides valuable training to prepare each Fellow to accept opportunities in academia or industry upon completion of the Lilly Fellowship.

During the two-year training period, Lilly provides each Fellow the opportunity to participate and complete research project(s) that encompass exploratory research, new technologies and/or novel methods to advance research and development related to the strategic interests of Lilly Research Laboratories worthy of publication in peer-reviewed scientific journals.

A mentor is assigned to each Fellow to assist in the training and coaching of each project and initiative in which the Fellow participates. State-of-the-art facilities and a strong scientific environment provide the Fellow with the resources necessary to complete the given assignment. Lilly also supports and encourages attendance at scientific meetings throughout the year to help further development.

Expectations of the Postdoctoral Fellow

Students selected for Lilly's Postdoctoral Fellow program are expected to:

Provide a good faith effort to accomplish the scientific objectives agreed upon when hired
Provide scientific influence within the laboratory and department via discussion and sharing of technical knowledge and experiences
Present at various scientific seminars within Lilly Research Laboratories (LRL) on work performed at Lilly
Write and submit at least one scientific paper to a peer-reviewed, high quality journal during Lilly tenure
Present at least one abstract at a national/international scientific meeting

Terms of Appointment

The initial Postdoctoral Fellow appointment is two years. After successful completion of the first year, the second year is automatically approved unless otherwise agreed upon with your mentor.

Extensions for third or fourth year Fellowships require special approval and will be determined on an individual basis.

Open Positions

To search for open Postdoctoral Fellow positions, follow the instructions below:

Click on Careers Search in the menu on the top right side of the screen
Select Post Doctorate under Job Type
Click the Search button

*Note: Postdoctoral Fellow positions are available periodically throughout the year. Please check back later if you are unable to locate any.

Research Publications

Atherosclerosis/Metabolic Syndrome

Zhao Y., Chen YQ., Bonacci, T.M., Bredt D.S., Li S., Bensch, W.R., Moller, D.E., Kowala, M., Konrad, R.J., Cao, G. Identification and characterization of a major liver lysophosphatidylcholine acyltransferase. Journal of Biological Chemistry (2008) Mar 28;283(13): 8258-65.

Cancer

Konicek, B.W., Dumstorf, C.A., Graff, J.R. Targeting the eIF4F translation initiation complex for cancer therapy. Cell Cycle (2008) Aug 15; 7(16): 2466-71

Low, J., Huang, S., Blosser, W., Dowless, M., and Stancato L. High Content Imaging Characterization of Cell Cycle Therapeutics Through In Vitro and In Vivo Subpopulation Analysis. Molecular Cancer Therapeutics (2008) Aug;7(8):2455-63

Integrative Biology

Saxena, C., Zhen E., Higgs, RE And Hale, JE. An immuno-chemo-proteomics method for drug target deconvolution. Journal of Proteome Research (2008) 7: 3490

Neuroscience

Ardayfio, P., Benvenga, M., Chaney, S., Love, P., Catlow, J., Swanson, S., Marek G.
The 5-hydroxytryptamine2A receptor antagonist M100907 attenuates impulsivity after both drug induced disruption (dizocilpine) and enhancement (antidepressant drugs) of Differential-Reinforcement-of-Low Rate 72-s behavior in the rat. Journal of Pharmacology and Experimental Therapeutics (2008) 327, 891-7

Fell, M.J., Svensson, K.A., Johnson, B.G., Schoepp, D.D.,. Evidence for mGlu2 and not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist LY404039. Journal of Pharmacology and Experimental Therapeutics (2008) 326(1):209-17

Kato, A.S., Siuda, E.R., Nisenbaum, E.S., Bredt, D.S. AMPA receptor subunit-specific regulation by a distinct family of Type II TARPs. Neuron (2008) 59: 986-996

Zhao, L, Lin. S., Bales K., Gelfanova, V., Koger, D., Delong, C., Hale, J., Liu, F., Hunter, J., Paul, S. Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanism. Journal of Neuroscience (2009) 29(11):3603–3612

Search for Opportunities in Post-Doctoral Program

Our Benefits

We believe in helping people live healthier, happier lives. That's why we give our employees a choice of benefits that best serve their needs.

> Click to view .pdf

Career Search

Career opportunities at Lilly abound at every level. Take the first step towards discovering the ones that match your disciplines and goals.

> Search Jobs

Our Products

Check out our portfolio of first-in-class and best-in-class pharmaceutical products.

> Find out More